Collaboration Details

Print  Close


Title of Collaborative Activity:

AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)

Description of Collaborative Activity:

The Bespoke Gene Therapy Consortium (BGTC) is a developing public-private partnership dedicated to making gene therapy a reality for people with rare genetic diseases affecting populations too small to be viable from the current commercial perspective.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2019

NIH Participating Institutes/Centers/Office of the Director:

NCATS, NHLBI, NIMH, NINDS

HHS Agency Collaborators on this Activity:

FDA